telogen effluvium tirzepatide In this week's episode of the Evidence Based Hair Podcast, I delve into a fascinating study from JAAD Case Reports, which explores the potential benefits of the diabetes drug terzepatide (Mounjaro, Zepbound) Losing Weight… But Losing Hair

At Nava Health, we offer semaglutide within our NavaRX weight loss program and monitor your progress carefully

Appetite suppression through dopamine modulation Central appetite control: Tesofensine acts on hypothalamus Affects arcuate nucleus (appetite center) Different pathway from GLP-1 receptors Direct neurotransmitter modulation Rapid onset (hours not days) Dopamine's role in eating: Mediates food reward (hedonic eating) High-dopamine = reduced food seeking Decreases obsessive food thoughts Reduces binge eating tendencies Similar to ADHD medication effects Subjective appetite changes reported: Reduced hunger (moderate, not as strong as semaglutide ) Less food preoccupation Earlier satiety (smaller portions satisfying) Reduced cravings especially for high-calorie foods More mental focus on non-food activities Appetite suppression comparison: Why dopamine approach different: Addresses psychological/behavioral eating Reduces food as reward behavior Helps with emotional eating Less GI side effects than GLP-1s But creates stimulant-like dependency risk Clinical trial results and efficacy Evidence from human studies

A commenter advised CMS to develop a claims-based approach to measure health disparities

One reviewer mentioned frustration at having to restart at a lower dose after a system change, which is something you want to avoid if possible